Dr. Muskovitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
44344 Dequindre
suite 260
Sterling Heights, MI 48314Phone+1 586-323-1500Fax+1 586-323-1515- Is this information wrong?
Summary
- Dr. Muskovitz is a graduate of Wayne State University School of Medicine, class of 2005. He completed Internal Medicine residency and Geriatric fellowship training at University of Illinois
Chicago, followed by Oncology and Hematology training at Karmanos. He practices general Medical Oncology and Hematology with the Cancer and Leukemia Center at Troy Beaumont, having joined the Troy medical staff in 2015 and Royal Oak in 2012. He has a clinical interest in caring for older adults with cancer problems and is one of a small number of physicians in the US who are dual certified in Geriatric Medicine and Oncology. Dr. Muskovitz assumed Medical Directorship of the Cancer Clinical Trial Office at Beaumont Health in August 2020.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Illinois College of Medicine at ChicagoFellowship, Geriatric Medicine (Internal Medicine), 2008 - 2009- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2005 - 2008
Wayne State University School of MedicineClass of 2005
Certifications & Licensure
MI State Medical License 2009 - 2027
IL State Medical License 2005 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Geriatric Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
- S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
- Join now to see all
Publications & Presentations
PubMed
- SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.Virginia Sun, Katherine A Guthrie, Tracy E Crane, Kathryn B Arnold, Sarah Colby, Sarah G Freylersythe, Christa Braun-Inglis, Roxanne Topacio, Craig A Messick, Joseph C...> ;Cancer. 2024 Feb 22
- 74 citationsEstrogen plus progestin and colorectal cancer incidence and mortality.Michael S. Simon, Rowan T. Chlebowski, Jean Wactawski-Wende, Karen C. Johnson, Andrew A. Muskovitz, Ikuko Kato, Alicia Young, F. Allan Hubbell, Ross L. Prentice> ;Journal of Clinical Oncology. 2012 Nov 10
- 14 citationsSynchronous moyamoya syndrome and ruptured cerebral aneurysm in Alagille syndrome.Ron C. Gaba, Rajesh Shah, Andrew A. Muskovitz, Grace Guzman, Edward A. Michals> ;Journal of Clinical Neuroscience. 2008 Dec 1
Hospital Affiliations
Corewell Health William Beaumont University HospitalRoyal Oak, Michigan
Corewell Health Troy HospitalTroy, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
